Cypress Capital Group’s Aehr Test Systems AEHR Stock Holding History

Cypress Capital Group’s Portfolio AEHR Stock Details AEHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$364K	Buy	+3,788	New	+$346K	0.03%	238

Other funds holding AEHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Bard Associates Chicago, Illinois $451M AUM 66.6% 1-Year Est. Return

PCM

Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Cypress Capital Group's AEHR Position: Q2 2026 in Review

Cypress Capital Group opened a new position in Aehr Test Systems (AEHR) in Q2 2026: 3,788 shares worth $364K. The stake represents 0.03% of the portfolio and ranks #238 among its holdings.

148 funds tracked by Wall St. Rank hold AEHR as of Q2 2026.

Cypress Capital Group held 3,788 shares of Aehr Test Systems worth $364K as of Q2 2026.
Aehr Test Systems was a new Cypress Capital Group position in Q2 2026.
Aehr Test Systems made up 0.03% of Cypress Capital Group's portfolio in Q2 2026, its #238 holding.
148 funds tracked by Wall St. Rank held Aehr Test Systems as of Q2 2026.

Based on Cypress Capital Group's 13F filing for Q2 2026, filed 5 Aug 2026.